PT-141 (Bremelanotide) 10 mg
$60.00
Selective MC3R/MC4R agonist — FDA-approved reference compound. ≥98% purity, 10 mg lyophilized. For laboratory research only.
- 🔒 Secure Checkout
- ↩️ 30-Day Easy Returns
- ⭐ Premium Quality Guaranteed
🛍️ Frequently Bought Together
🔒Secure Checkout
🚚Fast Shipping
↩️Easy Returns
✅Quality Guaranteed
Description
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist with selective activity at the MC3R and MC4R subtypes.
Research Profile
As an FDA-approved pharmaceutical (Vyleesi®), Bremelanotide is one of the most clinically validated melanocortin peptides. Unlike peripheral vasodilators, PT-141 acts centrally through hypothalamic melanocortin-4 receptor activation, modulating dopaminergic and oxytocinergic signaling. Research continues to explore its unique central mechanism of action and downstream neuroendocrine effects.
MC3R/MC4R AgonistFDA-Approved Reference10 mg Lyophilized≥98% Purity
This product is not a drug, dietary supplement, or food. It is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding biological activity, outcomes, or effects. By purchasing this product, the buyer acknowledges that it is for research use only and agrees to handle, store, and dispose of it in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.